Clinical Cardiovascular Medicine Research

Building the Future of Cardiology with Research

Beth Israel Deaconess Medical Center (BIDMC) is a leader in cardiovascular medicine research innovation. Coordinated by our clinical research council, we help deepen the understanding of this critical area of medicine to improve diagnostic and treatment options for our patients.

Spotlight Report

Collaboration with the Baim Institute

Named in honor of the late Donald Baim, MD, founder of the interventional cardiology program at Beth Israel Hospital and a pioneer in cardiology research, the Baim Institute for Clinical Research (formerly HCRI) specializes in the design and coordination of multi-center clinical trials as well as analysis of clinical research data from a wide variety of clinical disciplines, with special emphasis and expertise in cardiovascular diseases.

The Baim Institute is the hub where BIDMC researchers collaborate with biostatisticians, epidemiologists, clinical trialists, decision- and cost-effectiveness analysts to advance our clinical research initiatives.

Clinical Trials

The Baim Institute has conducted over 100 national and international medical device, pharmaceutical and biological trials, many leading to FDA approval for novel therapies, including intravascular brachytherapy, drug-eluting stents and distal-embolic protection devices.

Today, the Baim Institute is led by President and CEO C. Michael Gibson, MD, professor of medicine at Harvard Medical School and faculty member in BIDMC's interventional cardiology program.

BIDMC interventional cardiologist Donald Cutlip, MD, serves as the institute's chief operating officer. Robert W. Yeh, MD, MBA, and Peter J. Zimetbaum, MD, serve as Baim Institute faculty members, and Ernest Gervino, ScD, FACSM, serves as Baim Institute faculty advisor.